Cover Image
市場調查報告書

全球高內涵篩選市場,設備別(細胞影像化·分析系統)·各用途(一次·二次篩檢,目標識別·檢驗,毒性研究,化合物分析),軟體·服務:預測

High Content Screening Market by Instruments (Cell Imaging & Analysis System), by Applications (Primary & Secondary Screening, Target Identification & Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018

出版商 MarketsandMarkets 商品編碼 296131
出版日期 內容資訊 英文 151 Pages
訂單完成後即時交付
價格
Back to Top
全球高內涵篩選市場,設備別(細胞影像化·分析系統)·各用途(一次·二次篩檢,目標識別·檢驗,毒性研究,化合物分析),軟體·服務:預測 High Content Screening Market by Instruments (Cell Imaging & Analysis System), by Applications (Primary & Secondary Screening, Target Identification & Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018
出版日期: 2014年02月11日 內容資訊: 英文 151 Pages
簡介

近年來,在藥物開發的各個階段上高內涵篩選的引進有增加的趨勢。全球高內涵篩選市場在2013年為3億6,220萬美金的規模,之後預測將以CAGR11.2%的速度成長,到2018年達到6億1,580萬美金的規模。藥物研發初期階段確認毒性等級的必要性,政府對使用細胞的研究的輔助,及強化的資訊解決方案及功能改善的影像分析設備引進等,是推動該成長的要素。

本報告提供全球高內涵篩選市場相關研究,提供各設備·各用途·各終端用戶·各地區市場現況與展望相關調查分析,彙整競爭環境,再加上主要企業簡介等資料,為您概述為以下內容。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 市場發展推動因素
      • 藥物研發初期階段確認毒性等級的必要性
      • 政府對使用細胞的研究資金及風險企業資本投資促進市場成長
      • 強化的資訊解決方案及改善的影像分析設備的投入
    • 市場發展阻礙因素
      • 高內涵篩選系統的高成本有阻礙市場成長的可能性
    • 市場機會
      • 臨床研究委外機構(CRO)擁有提供HCS服務的莫大機會
      • 一次篩檢引進高內涵篩選
      • 個體化醫療上高內涵篩選的應用
      • 為促進HCS市場上信用的合作
    • 課題
      • 缺乏具有高內涵篩選知識的熟練專家
  • 市場佔有率分析

第4章 各產品類型

  • 簡介
  • 設備
    • 細胞影像化·分析系統
    • 流通量血球計算機
  • 消耗品
    • 試劑·樣品套件
    • 微孔盤
    • 其他的消耗品
  • 軟體
  • 服務

第5章 各用途

  • 簡介
    • 目標識別·檢驗
    • 一次篩檢·二次篩檢
    • 毒性實驗
    • 化合物分析
    • 其他的用途

第6章 各終端用戶

  • 製藥公司·生物科技企業
  • 學術·政府機關
  • 臨床研究委外機構(CRO)

第7章 各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞洲
  • ROW(其他地區)

第8章 競爭環境

  • 簡介
  • 新產品發表
  • 產業擴張
  • 協定,聯盟,夥伴關係
  • 收購

第9章 企業簡介(概要,財務實際成果,產品與服務,策略,最近的動向)

  • Becton, Dickinson and Company
  • Cell Signaling Technology, Inc.
  • Danaher Corporation
  • Ge Healthcare(General Electric Company的子公司)
  • Genedata Ag
  • Merck Kgaa
  • Perkinelmer, Inc.
  • thermo Fisher Scientific, Inc.
  • Thorlabs, Inc.
  • 橫河電機

圖表

目錄
Product Code: BT 2227

The global high content screening market is a technology-driven market and is marked by the 'Threat of Obsolescence,' wherein technologies as well as their adoption by end users changes very rapidly. Pharmaceutical and biotechnology companies as well as academic and government institutes are increasingly focusing on using high content screening as a powerful research tool in drug discovery. The high content screening software market is the fastest-growing segment in the high content screening market. In high content screening, the accuracy of the results obtained depends on image analysis and data management software. In recent years, enhanced image analysis and data management solutions have been introduced, but there is scope for these solutions to be further improvised to provide improved results. Many of the key players in the high content screening instruments market are collaborating with software companies to offer products with better software. For instance, in November 2010, PerkinElmer collaborated with Glencoe Software, Inc. to integrate Columbus Scope, a cellular imaging software solution for microscopy. With the data sharing facility, Columbus Scope helps in data management in high content screening.

In the coming years, Asian countries are expected to witness a high growth. These regions offer an array of opportunities for growth and are expected to be the new revenue pockets for high content screening. This region offers a high growth potential as compared to mature markets such as the U.S. Growth in the Asian market is spurred by government support for the development of innovative screening technologies and rising demand for outsourcing of drug discovery services. For instance, in September 2013, Global Health Innovative Technology Fund (GHIT Fund), granted $5.7 million to six global partnerships to support the R&D activities of these partnerships in the area of various infectious diseases like tuberculosis, malaria, and Chagas disease. Such fundings are expected to boost the growth of the high content screening market.

The global high content screening market is competitive and all the existing players in this market are engaged in developing new and advanced products to maintain their market shares.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help the firms in garnering a greater market share. Firms purchasing this report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios and services offered by the top players in the high content screening market. The report analyzes the high content screening market by application across geographies

Product Development/Innovation: Detailed insights on research and development activities and new product launches in the high content screening market

Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes promising applications of the high content screening market by product across geographies

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the high content screening market

Competitive Assessment: In-depth assessment of market shares, strategies, products and services, and distribution networks in the high content screening market

Table of Contents

1. Introduction

  • 1.1. Objectives of the Study
  • 1.2. Report Description
  • 1.3. Markets Covered
  • 1.4. Stakeholders
  • 1.5. Market Scope
  • 1.6. Research Methodology
    • 1.6.1. Market Size Estimation
    • 1.6.2. Market Crackdown and Data Triangulation
    • 1.6.3. Market Share
    • 1.6.4. Key Data Points From Primary Sources
    • 1.6.5. Key Data Points From Secondary Sources

2. Executive Summary

3. Market Overview

  • 3.1. Introduction
  • 3.2. Market Segmentation
  • 3.3. Market Dynamics
    • 3.3.1. Drivers
      • 3.3.1.1. Need For Determining Level of Toxicity in the Early Stages of Drug Discovery
      • 3.3.1.2. Government Funding and Venture Capital Investments in Cell-Based Research Will Drive the Market Growth
      • 3.3.1.3. Introduction of Enhanced Informatics Solutions and Improved Image Analysis Instruments
    • 3.3.2. Restraints
      • 3.3.2.1. High Cost of High Content Screening Systems May Hinder the Market Growth
    • 3.3.3. Opportunities
      • 3.3.3.1. Contract Research Organizations Have Significant Opportunities To Provide HCS Services
      • 3.3.3.2. Adoption of High Content Screening For Primary Screening
      • 3.3.3.3. Application of High Content Screening in Personalized Medicine
      • 3.3.3.4. Collaborations To Increase Innovation in the HCS Market
    • 3.3.4. Challenges
      • 3.3.4.1. Shortage of Knowledgeable and Skilled Professionals For High Content Screening
  • 3.4. Market Share Analysis

4. By Product Type

  • 4.1. Introduction
  • 4.2. Instruments
    • 4.2.1. Cell Imaging and Analysis Systems
    • 4.2.2. Flow Cytometers
  • 4.3. Consumables
    • 4.3.1. Reagents & Assay Kits
    • 4.3.2. Microplates
    • 4.3.3. Other Consumables
  • 4.4. Software
  • 4.5. Services

5. By Application

  • 5.1. Introduction
    • 5.1.1. Target Identification and Validation
    • 5.1.2. Primary Screening and Secondary Screening
    • 5.1.3. Toxicity Studies
    • 5.1.4. Compound Profiling
    • 5.1.5. Other Applications

6. By End Users

  • 6.1. Pharmaceutical and Biotechnology Companies
  • 6.2. Academia and Government Institutes
  • 6.3. Contract Research Organizations (CRO)

7. Geographic Analysis

  • 7.1. Introduction
  • 7.2. North America
  • 7.3. Europe
  • 7.4. Asia
  • 7.5. ROW

8. Competitive Landscape

  • 8.1. Introduction
  • 8.2. New Product Launch
  • 8.3. Expansions
  • 8.4. Agreements, Collabarations, Partnerships
  • 8.5. Acquisitions

9. Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)*

  • 9.1. Becton, Dickinson and Company
  • 9.2. Cell Signaling Technology, Inc.
  • 9.3. Danaher Corporation
  • 9.4. Ge Healthcare (Subsidiary of General Electric Company)
  • 9.5. Genedata Ag
  • 9.6. Merck Kgaa
  • 9.7. Perkinelmer, Inc.
  • 9.8. thermo Fisher Scientific, Inc.
  • 9.9. Thorlabs, Inc.
  • 9.10. Yokogawa Electric Corporation

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

List of Tables

  • Table 1: Global Market, By Product Type, 2011-2018 ($Million)
  • Table 2: HCS Products Market, By Geography, 2011-2018 ($Million)
  • Table 3: The Global High Content Screening Instruments Market, By Type, 2011-2018 ($Million)
  • Table 4: HCS Instruments Market, By Geography, 2011-2018 ($Million)
  • Table 5: Cell Imaging and Analysis HCS Systems Market, By Geography, 2011-2018 ($Million)
  • Table 6: HCS Flow Cytometers Market, By Geography, 2011-2018 ($Million)
  • Table 7: Global HCS Consumables Market, By Type, 2011-2018 ($Million)
  • Table 8: HCS Consumables Market, By Geography, 2011-2018 ($Million)
  • Table 9: HCS Reagents and Assay Kits Market, By Geography, 2011-2018 ($Million)
  • Table 10: HCS Microplates Market, By Geography, 2011-2018 ($Million)
  • Table 11: HCS Other Consumables Market, By Geography, 2011-2018 ($Million)
  • Table 12: HCS Software Market, By Geography, 2011-2018 ($Million)
  • Table 13: HCS Services Market, By Geography, 2011-2018 ($Million)
  • Table 14: Global HCS Applications Market, By Type, 2011-2018 ($Million)
  • Table 15: HCS Applications Market, By Geography, 2011-2018 ($Million)
  • Table 16: HCS Target Identification and Validation Market, By Geography, 2011-2018 ($Million)
  • Table 17: HCS Primary and Secondary Screening Market, By Geography, 2011-2018 ($Million)
  • Table 18: HCS Toxicity Studies Market, By Geography, 2011-2018 ($Million)
  • Table 19: HCS Compound Profiling Market, By Geography, 2011-2018 ($Million)
  • Table 20: HCS Other Applications Market, By Geography, 2011-2018 ($Million)
  • Table 21: Global Market, By End User, 2011-2018 ($Million)
  • Table 22: HCS End Users Market, By Geography ($Million)
  • Table 23: Pharmaceutical and Biotechnology Companies HCS Market, By Geography, 2011-2018 ($Million)
  • Table 24: Academia and Government Institutes HCS Market, By Geography, 2011-2018 ($Million)
  • Table 25: Contract Research Organization HCS Market, By Geography, 2011-2018 ($Million)
  • Table 26: HCS Product Market, By Geography, 2011-2018 ($Million)
  • Table 27: North America: Market, By Product Type, 2011-2018 ($Million)
  • Table 28: North America: HCS Instruments Market, By Type, 2011-2018 ($Million)
  • Table 29: North America: HCS Consumables Market, By Type, 2011-2018 ($Million)
  • Table 30: North America: Market, By Application Type, 2011-2018 ($Millions)
  • Table 31: North America: Market, By End User, 2011-2018 ($Million)
  • Table 32: Europe: Market, By Product Type, 2011-2018 ($Million)
  • Table 33: Europe: HCS Instruments Market, By Type, 2011-2018 ($Million)
  • Table 34: Europe: HCS Consumables Market, By Type, 2011-2018 ($Million)
  • Table 35: Europe: Market, By Application Type, 2011-2018 ($Million)
  • Table 36: Europe: Market, By End User, 2011-2018 ($Million)
  • Table 37: Asia: Market, By Product Type, 2011-2018 ($Million)
  • Table 38: Asia: HCS Instruments Market, By Type, 2011-2018 ($Million)
  • Table 39: Asia: HCS Consumables Market, By Type, 2011-2018 ($Million)
  • Table 40: Asia: Market, By Application, 2011-2018 ($Million)
  • Table 41: Asia: Market, By End User, 2011-2018 ($Million)
  • Table 42: ROW: Market, By Product Type, 2011-2018 ($Million)
  • Table 43: ROW: HCS Instruments Market, By Type, 2011-2018 ($Million)
  • Table 44: ROW: HCS Consumables Market, By Type, 2011-2018 ($Million)
  • Table 45: ROW: Market, By Application, 2011-2018 ($Million)
  • Table 46: ROW: Market, By End User, 2011-2018 ($Million)
  • Table 47: New Product Launch, 2011-2013
  • Table 48: Expansions, 2011-2013
  • Table 49: Agreements, Partnerships, Collabarations, 2011-2013
  • Table 50: Acquisitions, 2011-2013

List of Figures

  • Figure 1: Forecast Model
  • Figure 2: Market Size Estimation Methodology
  • Figure 3: Market Crackdown & Data Triangulation Methodology For the HCS Market
  • Figure 4: Global Market, By Product, 2013-2018 ($Million)
  • Figure 5: HCS Market, By Geography, 2013-2018 ($Million)
  • Figure 6: Market Segmentation
  • Figure 7: Market Dynamics
  • Figure 8: Global HCS Instruments Market Share, By Key Players, 2013
  • Figure 9: HCS Products Market, By Geography, 2013
  • Figure 10: Key Growth Strategies, HCS Market, 2011-2013
Back to Top